Prestigious Hadassah Medical Center Joins Yale, Johns Hopkins, Tel Aviv Sourasky and IMCA, in Evaluating the Company’s proprietary ...
FIH Clinical Trial Planning for Radiopharmaceuticals: From IND to Patient Dosing, Upcoming Webinar Hosted by Xtalks ...
How pharma–hospital partnerships can overcome operational, financial, and organizational barriers to build high-performing clinical trial programs that expand access, accelerate accrual, and ...
The top-line data from the first cohort demonstrate a favorable safety profile, with no serious adverse events reported and the treatment generally well-tolerated across all participants. Additionally ...
Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These ...
New research contributes valuable data that may help low-dose ketamine infusions become more widely accepted as a safe and ...
Prestigious Hadassah Medical Center Joins Yale, Johns Hopkins, Tel Aviv Sourasky and IMCA, in Evaluating the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate Vancouver, Canada ...
Two new research studies have launched to provide better evidence to support the needs of young people with gender ...
The FDA will submit a boxed warning and other labeling limits for Elevidys, an adeno-associated virus and vector-based gene ...
In 2026 and beyond, I predict that more pharmaceutical companies will use AI in their HCP marketing workflows—namely, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback